{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:49:55Z","timestamp":1793396995622,"version":"4.5.0"},"reference-count":32,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC CoG 818715, SECRETE-HF"],"award-info":[{"award-number":["ERC CoG 818715, SECRETE-HF"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["Grant agreement No 101095653"],"award-info":[{"award-number":["Grant agreement No 101095653"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON DOUBLE DOSE, grant 2020B005"],"award-info":[{"award-number":["CVON DOUBLE DOSE, grant 2020B005"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON PREDICT2, grant 2018-30"],"award-info":[{"award-number":["CVON PREDICT2, grant 2018-30"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON RED-CVD, grant 2017-11"],"award-info":[{"award-number":["CVON RED-CVD, grant 2017-11"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["CVON SHE-PREDICTS-HF, grant 2017-21"],"award-info":[{"award-number":["CVON SHE-PREDICTS-HF, grant 2017-21"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2024,10,26]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We evaluated the potential of circulating bone morphogenetic protein 10 (BMP10) as a biomarker for atrial stress and remodelling in patients with heart failure (HF), in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP). We also assessed the predictive value of BMP10 for adverse clinical outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>BMP10 levels were quantified in 2085 chronic HF patients from the European BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF) cohort and in 1487 patients from the Scottish validation cohort. Multivariable linear regression identified independent associates of BMP10. Proteomic analysis of 6369 proteins with subsequent gene set enrichment analysis was used to explore biological pathways associated with elevated BMP10. Cox proportional hazards models adjusting for established risk factors were used to associate BMP10 levels with clinical outcomes, including all-cause mortality and HF hospitalisation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In a multivariable model including clinical and echocardiographic parameters, log-transformed and standardised BMP10 levels were significantly associated with a history of atrial fibrillation (S\u03b2=0.419; p&lt;0.001), and with echocardiographic features reflecting atrial stress, such as increased left atrial diameter (S\u03b2=0.075; p=0.048). By contrast, these were not among the strongest associates of NT-proBNP levels. Gene set enrichment analysis showed significant overrepresentation in pathways of muscle contraction and extracellular matrix organisation. Higher log-transformed and standardised BMP10 levels predicted a combined outcome of 2-year all-cause mortality and HF rehospitalisation (HR=1.10, 95% CI=1.02\u20131.19), with the validation cohort yielding comparable results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>BMP10 emerges as a novel biomarker reflecting atrial stress and remodelling in chronic HF patients. Its additional predictive value for adverse outcomes underscores its potential utility in enhancing risk stratification and guiding therapeutic interventions in HF management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2024-324486","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T13:25:19Z","timestamp":1732886719000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure"],"prefix":"10.1136","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-2165","authenticated-orcid":false,"given":"Daan C H","family":"Ceelen","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bracun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J","family":"van Essen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-4415","authenticated-orcid":false,"given":"Adriaan A","family":"Voors","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Centre, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozine M","family":"ter Maaten","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, Groningen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Masson","sequence":"additional","affiliation":[{"name":"Roche Diagnostics International AG, Rotkreuz, Zug, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kastner","sequence":"additional","affiliation":[{"name":"Roche Diagnostics GmbH, Penzberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chim C","family":"Lang","sequence":"additional","affiliation":[{"name":"Cardiology, Ninewells Hospital and Medical School, Dundee, UK"},{"name":"Tuanku Muhriz Chair, National University of Malaysia, Bandar Baru Bangi, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Suthahar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, Groningen, Netherlands"},{"name":"Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Centre, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"2025092000270859000_111.4.172.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092000270859000_111.4.172.2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.601364"},{"key":"2025092000270859000_111.4.172.3","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10105-w"},{"key":"2025092000270859000_111.4.172.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312706"},{"key":"2025092000270859000_111.4.172.5","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2018.1460576"},{"key":"2025092000270859000_111.4.172.6","doi-asserted-by":"publisher","DOI":"10.7150\/thno.26055"},{"key":"2025092000270859000_111.4.172.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09807-z"},{"key":"2025092000270859000_111.4.172.8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139179","article-title":"Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation","volume":"5","author":"Reyat","year":"2020","journal-title":"JCI Insight"},{"key":"2025092000270859000_111.4.172.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4773(98)00221-4"},{"key":"2025092000270859000_111.4.172.10","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1988"},{"key":"2025092000270859000_111.4.172.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.10.003"},{"key":"2025092000270859000_111.4.172.12","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-022-09859-0"},{"key":"2025092000270859000_111.4.172.13","doi-asserted-by":"crossref","unstructured":"E Molina C , Sommerfeld L , Zeller T , et al . From cells to circulating biomarker: BMP10 is a myocyte-secreted peptide with potential to detect atrial fibrillation. Eur Heart J 2023;44. doi:10.1093\/eurheartj\/ehad655.3140","DOI":"10.1093\/eurheartj\/ehad655.3140"},{"key":"2025092000270859000_111.4.172.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047375"},{"key":"2025092000270859000_111.4.172.15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010943"},{"key":"2025092000270859000_111.4.172.16","first-page":"1868","article-title":"Bone morphogenetic protein-10 induces cardiomyocyte proliferation and improves cardiac function after myocardial infarction","volume":"115","author":"Sun","year":"2014","journal-title":"J Cell Biochem"},{"key":"2025092000270859000_111.4.172.17","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2048994"},{"key":"2025092000270859000_111.4.172.18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028255","article-title":"Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation","volume":"12","author":"Hennings","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025092000270859000_111.4.172.19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac632"},{"key":"2025092000270859000_111.4.172.20","doi-asserted-by":"crossref","first-page":"33720","DOI":"10.1161\/JAHA.123.033720","article-title":"Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation:Insights From the ARISTOTLE Trial","volume":"13","author":"Gkarmiris","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2025092000270859000_111.4.172.21","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.531"},{"key":"2025092000270859000_111.4.172.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"2025092000270859000_111.4.172.23","doi-asserted-by":"crossref","unstructured":"Kim CH , Tworoger SS , Stampfer MJ , et al . Stability and reproducibility of proteomic profiles measured with an aptamer-based platform. Sci Rep 2018;8. doi:10.1038\/s41598-018-26640-w","DOI":"10.1038\/s41598-018-26640-w"},{"key":"2025092000270859000_111.4.172.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of Variability in the SOMAscan Assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep"},{"key":"2025092000270859000_111.4.172.25","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.785"},{"key":"2025092000270859000_111.4.172.26","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2562"},{"key":"2025092000270859000_111.4.172.27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00311.2007"},{"key":"2025092000270859000_111.4.172.28","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13020242","article-title":"Identification of BMP10 as a Novel Gene Contributing to Dilated Cardiomyopathy","volume":"13","author":"Gu","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2025092000270859000_111.4.172.29","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab187"},{"key":"2025092000270859000_111.4.172.30","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90787-2"},{"key":"2025092000270859000_111.4.172.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2147-x"},{"key":"2025092000270859000_111.4.172.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.08.005"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2024-324486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T07:27:21Z","timestamp":1758353241000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2024-324486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,1,29]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/heartjnl-2024-324486"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2024-324486","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}